Literature DB >> 25294353

Evaluation of proliferating cell abundance and phenotypes in proliferative diabetic retinopathy.

Richard M Feist1, Jeffery L King, Richard M Feist1, John O Mason, Robert E Morris, Clyde Guidry.   

Abstract

BACKGROUND: The aim of this work is to evaluate the abundance, origins, and phenotypes of actively proliferating cells in proliferative diabetic retinopathy (PDR).
METHODS: Eleven epiretinal membranes from patients undergoing surgery for PDR were evaluated by indirect immunofluorescence for evidence of cell proliferation using the nuclear cell proliferation marker Ki67 and for cell identities using glial fibrillary acidic protein (GFAP), glutamine synthetase, and α-smooth muscle actin (αSMA).
RESULTS: Ki67 positivity was consistently rare in PDR epiretinal membranes at 3.02 ± 1.42 % of the total cell population. The majority of the Ki67-positive cells were also positive for GFAP (74.0 %) with lower proportions positive for αSMA (30.7 %) and glutamine synthetase (1.5 %). Co-localization studies using glial and myoid markers revealed that virtually all (92 %) of the αSMA-positive cells are also GFAP positive and thus derive from glia.
CONCLUSIONS: Entry into cell cycle and thus cell proliferation appears to be a rare phenomenon in PDR involving only a small percentage of the total cell population. Glia and/or glial-derived myofibroblasts appear to be the predominate cell types in epiretinal scar tissues and also account for the majority of the actively proliferating cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25294353     DOI: 10.1007/s00417-014-2787-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  24 in total

1.  Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases.

Authors:  H P Heidenkummer; A Kampik; B Petrovski
Journal:  Retina       Date:  1992       Impact factor: 4.256

Review 2.  The role of Müller cells in fibrocontractive retinal disorders.

Authors:  Clyde Guidry
Journal:  Prog Retin Eye Res       Date:  2005-01       Impact factor: 21.198

Review 3.  Matrix and the retinal pigment epithelium in proliferative retinal disease.

Authors:  P Hiscott; C Sheridan; R M Magee; I Grierson
Journal:  Prog Retin Eye Res       Date:  1999-03       Impact factor: 21.198

Review 4.  New functions of Müller cells.

Authors:  Andreas Reichenbach; Andreas Bringmann
Journal:  Glia       Date:  2013-02-26       Impact factor: 7.452

5.  Epiretinal and vitreous membranes. Comparative study of 56 cases.

Authors:  A Kampik; K R Kenyon; R G Michels; W R Green; Z C de la Cruz
Journal:  Arch Ophthalmol       Date:  1981-08

6.  The fate of Müller's glia following experimental retinal detachment: nuclear migration, cell division, and subretinal glial scar formation.

Authors:  Geoffrey P Lewis; Ethan A Chapin; Gabriel Luna; Kenneth A Linberg; Steven K Fisher
Journal:  Mol Vis       Date:  2010-07-15       Impact factor: 2.367

7.  Epiretinal membrane of proliferative diabetic retinopathy: an immunohistochemical study.

Authors:  Y Hosoda; M Okada; M Matsumura; N Ogino; Y Honda; Y Nagai
Journal:  Ophthalmic Res       Date:  1993       Impact factor: 2.892

8.  Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations.

Authors:  P Esser; K Heimann; P Wiedemann
Journal:  Br J Ophthalmol       Date:  1993-11       Impact factor: 4.638

9.  Isolation and characterization of porcine Müller cells. Myofibroblastic dedifferentiation in culture.

Authors:  C Guidry
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-04       Impact factor: 4.799

10.  Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study.

Authors:  R F Hamman; E J Mayer; G A Moo-Young; W Hildebrandt; J A Marshall; J Baxter
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.